AT256457T
Gelatine encapsulated solution dosage forms of sertraline
Abstract
Sertraline is encapsulated in the invention involved in water immiscible carrier formulations, can shorten the dosage form Tmax and/or reduce side effects and/or reducing the use of sertraline in chloride-containing environments such as precipitation in the gastro-intestinal.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
56 members in 42 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 5140197 | United States of America | P | |
| 9800936 | International Bureau of the World Intellectual Property Organization (WIPO) | W |
Members56
| Document | Office | Kind | |
|---|---|---|---|
| MA24586A1 | Morocco | A1 | |
| CA2290973A1 | Canada | A1 | |
| WO9901113A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7545098A | Australia | A | |
| HRP980378A2 | Croatia | A2 | |
| PE97299A1 | Peru | A1 | |
| IS5266A | Iceland | A | |
| GT199800090A | Guatemala | A | |
| NO996492D0 | Norway | D0 | |
| ZA985709B | South Africa | B | |
| TW382597B | Taiwan Province of China | B | |
| EP0980241A1 | European Patent Office (EPO) | A1 | |
| NO996492L | Norway | L | |
| PA8454001A1 | Panama | A1 | |
| BR9809712A | Brazil | A | |
| CO4940405A1 | Colombia | A1 | |
| ID24673A | Indonesia | A | |
| BG103917A | Bulgaria | A | |
| CN1261792A | China | A | |
| TR199903282T2 | Türkiye | T2 | |
| EA199900963A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PL337807A1 | Poland | A1 | |
| JP2000512316A | Japan | A | |
| AU724635B2 | Australia | B2 | |
| HU0002250A2 | Hungary | A2 | |
| HUP0002250A2 | Hungary | A2 | |
| UY25070A1 | Uruguay | A1 | |
| SK180599A3 | Slovakia | A3 | |
| HU0002250A3 | Hungary | A3 | |
| HUP0002250A3 | Hungary | A3 | |
| KR20010013588A | Republic of Korea | A | |
| AP945A | African Regional Intellectual Property Organization (ARIPO) | A | |
| IL133075D0 | Israel | D0 | |
| AR015916A1 | Argentina | A1 | |
| EA001905B1 | Eurasian Patent Organization (EAPO) | B1 | |
| HRP980378B1 | Croatia | B1 | |
| OA11246A | African Intellectual Property Organization (OAPI) | A | |
| SK282914B6 | Slovakia | B6 | |
| KR100371730B1 | Republic of Korea | B1 | |
| DZ2544A1 | Algeria | A1 | |
| CA2290973C | Canada | C | |
| US2003133974A1 | United States of America | A1 | |
| EP0980241B1 | European Patent Office (EPO) | B1 | |
| AT256457TThis record | Austria | T | |
| ATE256457T1 | Austria | T1 | |
| DE69820608D1 | Germany | D1 | |
| PT980241E | Portugal | E | |
| DK0980241T3 | Denmark | T3 | |
| SI0980241T1 | Slovenia | T1 | |
| ES2210760T3 | Spain | T3 | |
| UA68350C2 | Ukraine | C2 | |
| JP3585245B2 | Japan | B2 | |
| NZ501252A | New Zealand | A | |
| DE69820608T2 | Germany | T2 | |
| TNSN98123A1 | Tunisia | A1 | |
| MY119728A | Malaysia | A |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 98923021
Titles2
- German
- IN GELATINE EINGEKAPSELTE SERTARLINE DOSIERUNGSFORMEN
- English
- GELATINE-CAPPED SERTARLINE DOSAGE FORMS
Classification
- CPC, 9
- A61K9/4858
- A61K9/48
- A61K31/135
- A61P3/04
- A61P15/00
- A61P25/00
- A61P25/24
- A61P25/30
- A61P43/00
- IPC, 7
- A61K9 48
- A61K9 66
- A61K31 135
- A61P3 04
- A61P25 00
- A61P25 24
- A61P43 00